CO46274 - Inavolisib plus Ribociclib plus Fulvestrant in advanced Breast Cancer

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1012986

• Contact name

  NA NA

• Contact email

  medinfo.uk@roche.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2025-523013-28

• Clinicaltrials.gov Identifier

  NCT07405801

• Research summary

  Publication of this data is currently deferred.

• REC name

  North West - Greater Manchester South Research Ethics Committee

• REC reference

  26/NW/0002

• Date of REC Opinion

  10 Mar 2026

• REC opinion

  Further Information Favourable Opinion